scienceJul 2, 202412:08pending

Immunotherapy in “Hardest Stage” of NSCLC: Putting Recent Advances Into Practice

About this episode

Our host, Robert A. Figlin, MD, FACP, welcomes Melissa L. Johnson, MD, as a guest

Get every episode summarized

Each time Oncology News Central Peer-Spectives publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

OOncololgy News CentralHost

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

More episodes

Immunotherapy in “Hardest Stage” of NSCLC: Putting Recent Advances Into Practice

About this episode

Get every episode summarized

Hosts & guests

More from Oncology News Central Peer-Spectives

Tackling “the Biggest Question That Everyone Is Asking” in Breast Cancer Care

Shared Decision Making and Toxicity Management in EGFR- Mutated Advanced NSCLC

“Where the Real Answer Lies”: How CNS Disease Influences EGFR-Mutated NSCLC Trea...

“Is the Juice Worth the Squeeze?”: Treatment Intensification for Advanced EGFRm...